Oncology Anastradex ® anastrazole Androstat ® cyproterone acetate Bialko ® pazopanib Bidrostat ® bicalutamide Biozanib ® cabozantinib Carboxtie ® carboplatin Cosmegen ® dactinomycin Dalcara ® Sorafenib Dimere ® fulvestrant Donataxel ® docetaxel Doxtie ® doxorubicin hydrochloride Flutrax ® flutamide Gembio ® gemcitabine Gombrich ® Cabazitaxel Idelara ® letrozole Irinogen ® irinotecan hydrochloride Kestava ® abiraterone acetate Mitotie ® mitomycin Mitoxgen ® mitoxantrone Oxaltie ® oxaliplatin Panataxel ® paclitaxel Postep ® erlotinib Sinresor ® zoledronic acid Sukuba ® pemetrexed Tamoxis ® tamoxifen Temaste ® trifluridine + tipiracil Vetrano ® palbociclib Vinorgen Oral ® vinorelbina Vp-Gen ® etoposide Xitabin ® capecitabineView all See leaflet Idelara® letrozole Indications Breast cancer. Presentations 2,5 mg x 30 tablets
See leaflet
